DLD Asset Management LP purchased a new position in LHC Group, Inc. (NASDAQ:LHCG – Get Rating) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 90,000 shares of the health services provider’s stock, valued at approximately $14,017,000. LHC Group makes up approximately 1.0% of DLD Asset Management LP’s investment portfolio, making the stock its 25th biggest holding. DLD Asset Management LP owned about 0.29% of LHC Group as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of the stock. Grantham Mayo Van Otterloo & Co. LLC purchased a new stake in shares of LHC Group during the 2nd quarter valued at about $12,689,000. Public Sector Pension Investment Board purchased a new stake in shares of LHC Group during the 2nd quarter valued at about $7,180,000. BNP Paribas Arbitrage SA raised its position in shares of LHC Group by 4.2% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 9,873 shares of the health services provider’s stock valued at $1,538,000 after buying an additional 395 shares in the last quarter. Rhumbline Advisers raised its position in shares of LHC Group by 7.0% during the 2nd quarter. Rhumbline Advisers now owns 95,907 shares of the health services provider’s stock valued at $14,937,000 after buying an additional 6,295 shares in the last quarter. Finally, Bridgewater Associates LP raised its position in shares of LHC Group by 7.7% during the 2nd quarter. Bridgewater Associates LP now owns 47,195 shares of the health services provider’s stock valued at $7,350,000 after buying an additional 3,369 shares in the last quarter. Hedge funds and other institutional investors own 87.82% of the company’s stock.
LHC Group Trading Down 0.0 %
LHC Group stock traded down $0.03 during midday trading on Thursday, reaching $167.98. The stock had a trading volume of 163,077 shares, compared to its average volume of 308,218. The company has a quick ratio of 1.45, a current ratio of 1.45 and a debt-to-equity ratio of 0.44. LHC Group, Inc. has a 52-week low of $108.42 and a 52-week high of $169.84. The firm has a market cap of $5.21 billion, a price-to-earnings ratio of 81.94, a price-to-earnings-growth ratio of 23.63 and a beta of 0.45. The company has a fifty day moving average of $165.66 and a 200 day moving average of $163.46.
Analysts Set New Price Targets
LHC Group Profile
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI).
- Get a free copy of the StockNews.com research report on LHC Group (LHCG)
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Is the 60/40 Portfolio Mix Still in Vogue?
- Microsoft Shares: Is it Time to Back Up the Truck?
- Institutional Support for Analog Devices Remains High
- Three CBD Stocks to Dominate a Budding Industry
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.